Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 27, Status: Authorised
European Medicines Agency Write PMS API implementation Guide
Guidelines Consistency Group
Applications for new human medicines under evaluation: November 2025
Human medicines European public assessment report (EPAR): Erivedge, vismodegib, Date of authorisation: 12/07/2013, Date of refusal: 26/04/2013, Revision: 16, Status: Authorised
Minutes - PDCO minutes of the 9-12 September 2025 meeting
Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 7, Status: Authorised
Timetable: Post-authorisation measures (PAMs) assessed by PRAC - ATMP
Minutes of the PRAC meeting 2-5 June 2025